204 related articles for article (PubMed ID: 32627171)
1. Brain control of appetite during sickness.
Aviello G; Cristiano C; Luckman SM; D'Agostino G
Br J Pharmacol; 2021 May; 178(10):2096-2110. PubMed ID: 32627171
[TBL] [Abstract][Full Text] [Related]
2. Cellular metabolism and diseases.
Maiuri MC; Maffia P
Br J Pharmacol; 2021 May; 178(10):2031-2033. PubMed ID: 33932230
[TBL] [Abstract][Full Text] [Related]
3. Complement, inflammation and thrombosis.
Rawish E; Sauter M; Sauter R; Nording H; Langer HF
Br J Pharmacol; 2021 Jul; 178(14):2892-2904. PubMed ID: 33817781
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation.
Certo M; Elkafrawy H; Pucino V; Cucchi D; Cheung KCP; Mauro C
Br J Pharmacol; 2021 May; 178(10):2041-2059. PubMed ID: 31999357
[TBL] [Abstract][Full Text] [Related]
5. Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness.
Yoshikawa T; Nakamura T; Yanai K
Br J Pharmacol; 2021 Feb; 178(4):750-769. PubMed ID: 32744724
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.
Navarro MN; Gómez de Las Heras MM; Mittelbrunn M
Br J Pharmacol; 2022 May; 179(9):1839-1856. PubMed ID: 33817782
[TBL] [Abstract][Full Text] [Related]
7. Immunity and hypertension: New targets to lighten the pressure.
Vinh A; Drummond GR; Sobey CG
Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
[TBL] [Abstract][Full Text] [Related]
8. Oxysterols: From physiological tuners to pharmacological opportunities.
Brown AJ; Sharpe LJ; Rogers MJ
Br J Pharmacol; 2021 Aug; 178(16):3089-3103. PubMed ID: 32335907
[TBL] [Abstract][Full Text] [Related]
9. The oxysterome and its receptors as pharmacological targets in inflammatory diseases.
Guillemot-Legris O; Muccioli GG
Br J Pharmacol; 2022 Nov; 179(21):4917-4940. PubMed ID: 33817775
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol and oxysterol sulfates: Pathophysiological roles and analytical challenges.
Sanchez LD; Pontini L; Marinozzi M; Sanchez-Aranguren LC; Reis A; Dias IHK
Br J Pharmacol; 2021 Aug; 178(16):3327-3341. PubMed ID: 32762060
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.
Stephenson E; Savvatis K; Mohiddin SA; Marelli-Berg FM
Br J Pharmacol; 2017 Nov; 174(22):3914-3925. PubMed ID: 27590129
[TBL] [Abstract][Full Text] [Related]
12. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of cancer prevention by nicotinamide.
Buqué A; Bloy N; Kroemer G; Galluzzi L
Br J Pharmacol; 2021 May; 178(10):2034-2040. PubMed ID: 32383227
[TBL] [Abstract][Full Text] [Related]
14. Function and regulation of GPR84 in human neutrophils.
Forsman H; Dahlgren C; Mårtensson J; Björkman L; Sundqvist M
Br J Pharmacol; 2024 May; 181(10):1536-1549. PubMed ID: 36869866
[TBL] [Abstract][Full Text] [Related]
15. Integrins meet complement: The evolutionary tip of an iceberg orchestrating metabolism and immunity.
Merle NS; Singh P; Rahman J; Kemper C
Br J Pharmacol; 2021 Jul; 178(14):2754-2770. PubMed ID: 32562277
[TBL] [Abstract][Full Text] [Related]
16. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh P; Grassia G; Botha S; Sattar N; Maffia P
Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
[TBL] [Abstract][Full Text] [Related]
17. ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello G; Knaus UG
Br J Pharmacol; 2017 Jun; 174(12):1704-1718. PubMed ID: 26758851
[TBL] [Abstract][Full Text] [Related]
18. Current and future treatments of pulmonary arterial hypertension.
Sommer N; Ghofrani HA; Pak O; Bonnet S; Provencher S; Sitbon O; Rosenkranz S; Hoeper MM; Kiely DG
Br J Pharmacol; 2021 Jan; 178(1):6-30. PubMed ID: 32034759
[TBL] [Abstract][Full Text] [Related]
19. The role of mitochondrial dynamics in cardiovascular diseases.
Forte M; Schirone L; Ameri P; Basso C; Catalucci D; Modica J; Chimenti C; Crotti L; Frati G; Rubattu S; Schiattarella GG; Torella D; Perrino C; Indolfi C; Sciarretta S;
Br J Pharmacol; 2021 May; 178(10):2060-2076. PubMed ID: 32294237
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance.
Puppo M; Taipaleenmäki H; Hesse E; Clézardin P
Br J Pharmacol; 2021 May; 178(9):1936-1954. PubMed ID: 31423566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
